
Serum lipidomic signatures distinguish hepatic steatosis from fibrosis in non-obese inflammatory arthritis, even at low disease activity
A Spanish single-centre cross-sectional study in 88 non-obese inflammatory arthritis

A Spanish single-centre cross-sectional study in 88 non-obese inflammatory arthritis

The urticaria sessions reinforced an emerging consensus that chronic spontaneous

A preregistered propensity score-matched cohort study across approximately 300,000 matched

A prospective single-centre observational series of omalizumab in paediatric chronic

An assessment of where endotype-directed prescribing now stands following two

A guideline-focused teaching lecture covering classification, diagnostic work-up and treat-to-target

An expert overview of pathomechanism and the emerging therapeutic pipeline,

An expert overview of pathomechanism and the emerging therapeutic pipeline,

SETTING THE SCENE JAK1 inhibition in AD has been validated

SETTING THE SCENE Both JAK1 inhibitors and dupilumab produce impressive

SETTING THE SCENE Facial AD in children with skin of

SETTING THE SCENE The 2% crisaborole formulation is one of